Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study
Objective: to study the efficacy and safety of the Gam-COVID-Vac vaccine in patients with immunoinflammatory rheumatic diseases (IRD) in a prospective study.Material and methods. The study included 42 patients with IRD and 57 individuals without IRD (control group) who received at least one componen...
Saved in:
Main Authors: | A. N. Kulikov, N. V. Muravyeva, B. S. Belov, G. I. Gridneva, E. S. Aronova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2023-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1506 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data
by: A. N. KULIKOV, et al.
Published: (2022-11-01) -
Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)
by: A. N. Kulikov, et al.
Published: (2022-02-01) -
Efficacy, Immunogenicity, and Safety of the Combined Vector Vaccine Gam-COVID-Vac in Patients with Rheumatic Diseases
by: A. N. Kulikov, et al.
Published: (2024-11-01) -
The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news
by: A. N. Kulikov, et al.
Published: (2023-06-01) -
Immunological Potency, Efficacy, and Tolerance of “Gam-COVID-Vac” Vaccine among Students: Prospective Study
by: Diana V. Sutovskaya, et al.
Published: (2022-05-01)